| P50 | author | Brian Edlin | Q43185278 |
| | Benjamin Eckhardt | Q59155860 |
| | Don C Des Jarlais | Q59824152 |
| | Courtney McKnight | Q37127031 |
| P2093 | author name string | Marshall J Glesby | |
| | Kristen Marks | |
| | Michael R Carden | |
| | Marla A Shu | |
| | Emily R Winkelstein | |
| P2860 | cites work | Syringe exchange and risk of infection with hepatitis B and C viruses | Q42691172 |
| | Hepatitis C virus seroconversion among young injection drug users: relationships and risks | Q43041146 |
| | More rare birds, and the occasional swan | Q43117957 |
| | Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco | Q43657708 |
| | Hepatitis C virus in intravenous drug users. | Q44943177 |
| | Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment | Q45733180 |
| | Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. | Q55240560 |
| | Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City | Q64129844 |
| | Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif | Q73466642 |
| | The burgeoning HIV/HCV syndemic in the urban Northeast: HCV, HIV, and HIV/HCV coinfection in an urban setting | Q21559628 |
| | A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs | Q24629455 |
| | Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study | Q24650146 |
| | Perspective: test and treat this silent killer | Q27332812 |
| | Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007 | Q28533642 |
| | Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012. | Q30209037 |
| | Prevalence, characteristics, and predictors of police training initiatives by US SEPs: building an evidence base for structural interventions | Q30404240 |
| | A police education programme to integrate occupational safety and HIV prevention: protocol for a modified stepped-wedge study design with parallel prospective cohorts to assess behavioural outcomes | Q30488207 |
| | Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. | Q30957144 |
| | Outreach-based HIV prevention for injecting drug users: a review of published outcome data | Q32030728 |
| | Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. | Q34178819 |
| | Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City | Q34602741 |
| | Supervised injection services: what has been demonstrated? A systematic literature review | Q35471492 |
| | Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013. | Q35690302 |
| | Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study | Q36021369 |
| | The influence of a peer-based HIV prevention intervention on conversation about HIV prevention among people who inject drugs in Baltimore, Maryland | Q36052814 |
| | Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. | Q36548225 |
| | Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000. | Q36575203 |
| | Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention | Q37042431 |
| | Evolving epidemiology of hepatitis C virus in the United States | Q38020157 |
| | Estimating the cost-effectiveness of needle-syringe programs in Australia. | Q39565081 |
| | Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012. | Q40278327 |
| | Correlates of hepatitis C virus infections among injection drug users. | Q40453200 |
| | HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015. | Q40596722 |
| | Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013. | Q40754700 |
| | Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013. | Q40769735 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0177341 | |
| P577 | publication date | 2017-05-19 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention | |
| P478 | volume | 12 | |